195. Yarborough, B. J., Stumbo, S. P., McCarty, D., Mertens, J., Weisner, C., & Green, C. A. (2016). Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis. Drug and alcohol dependence, 160, 112–118. https://doi. org/10.1016/j.drugalcdep.2015.12.031 196. Fudin, J. (2018). Opioid Agonists, Partial Agonists, Antagonists: Oh My! Retrieved September 6, 2022 from https://www.pharmacytimes.com/contributor/ jeffrey-fudin/2018/01/opioid-agonists-partial- agonists-antagonists-oh-my 197. Substance Abuse and Mental Health Services Administration (SAMHSA). (2018). SAMHSA opioid overdose prevention toolkit. HHS Publication No. (SMA) 18–4742. Substance Abuse and Mental Health Services Administration. https://store. samhsa.gov/system/files/sma18-4742.pdf 198. Food and Drug Administration. (2016). FDA adviso- ry committee on the most appropriate dose or dos- es of naloxone to reverse the effects of life-threat- ening opioid overdose in the community settings. Retrieved September 6, 2022 from https://www.fda. gov/downloads/AdvisoryCommittees/Committees- MeetingMaterials/Drugs/AnestheticAndAnalgesic- DrugProductsAdvisoryCommittee/UCM522688.pdf 199. Soyka M. (2017). Treatment of Benzodiazepine Dependence. The New England journal of medicine, 376(12), 1147–1157. https://doi. org/10.1056/NEJMra1611832 200. Schmitz A. (2016). Benzodiazepine use, misuse, and abuse: A review. The mental health clinician, 6(3), 120–126. https://doi.org/10.9740/ mhc.2016.05.120 201. Park, Tae Woo. (2022). Benzodiazepine use disorder. Retrieved September 2, 2022 from https:// www.uptodate.com/contents/benzodiazepine-use- disorder 202. National Institute on Alcohol Abuse and Alcoholism. (2021). Understanding Alcohol Use Disorder. Retrieved September 5, 2022 from https://www. niaaa.nih.gov/publications/brochures-and-fact- sheets/understanding-alcohol-use-disorder 203. Centers for Disease Control and Prevention (CDC). (2022). Excessive drinking is draining the US economy. Retrieved September 5, 2022 from https://www.cdc.gov/alcohol/features/excessive- drinking.html. 204. Reus, V. I., Fochtmann, L. J., Bukstein, O., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M., Mahoney, J., Pasic, J., Weaver, M., Wills, C. D., McIntyre, J., Kidd, J., Yager, J., & Hong, S. H. (2018). The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. The American journal of psychiatry, 175(1), 86–90. Retrieved September 5, 2022 from https://doi.org/10.1176/appi. ajp.2017.1750101 205. UC Santa Cruz. (2019). Alcohol and your body. Retrieved September 5, 2022 from https://shop. ucsc.edu/alcohol-other-drugs/alcohol/your-body. html#:~:text=Approximately%2020%25%20 of%20alcohol%20is,understanding%20the%20 effects%20of%20alcohol. 206. Stanford University. (2021). What is BAC? Retrieved September 5, 2022 from https://super.stanford. edu/alcohol-drug-info/buzz-buzz/what-bac 207. Dugdale, D. (2021). Alcohol withdrawal. National Library of Medicine: Medline Plus. Retrieved September 5, 2022 from https://medlineplus.gov/ ency/article/000764.htm
208. Edelman, E. J., & Fiellin, D. A. (2016). In the Clinic. Alcohol Use. Annals of internal medicine, 164(1), ITC1–ITC16. https://doi.org/10.7326/ AITC201601050 209. Patel R, Mueller M. (2022). Alcoholic Liver Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Retrieved September 5, 2022 from https://www.ncbi.nlm.nih. gov/books/NBK546632/ 210. Klochkov A, Kudaravalli P, Lim Y, et al. (2022). Alcoholic Pancreatitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Retrieved September 5, 2022 from https:// www.ncbi.nlm.nih.gov/books/NBK537191/ 211. Tetrault, J. M. & O’Connor, P. G. (2021). Risky drinking and alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis. UpToDate. Retrieved September 5, 2022 from https://www.uptodate. com/contents/risky-drinking-and-alcohol-use- disorder-epidemiology-pathogenesis-clinical- manifestations-course-assessment-and-diagnosis 212. Hoffman, R. S. & Weinhouse, G. L. (2021). Management of moderate and severe alcohol withdrawal syndromes. UpToDate. Retrieved September 6, 2022 from https://www.uptodate. com/contents/management-of-moderate-and- severe-alcohol-withdrawal-syndromes 213. Kim, Y., Hack, L. M., Ahn, E. S., & Kim, J. (2018). Practical outpatient pharmacotherapy for alcohol use disorder. Drugs in Context, 7, 212308. doi: 10.7573/dic.212308. 214. Stahl, S. (2020). Essential Psychopharmacology: prescribers guide. 7th edition. Cambridge University Press. 215. Holt, S. R. (2021). Alcohol use disorder: Pharmacologic management. UpToDate. Retrieved September 6, 2022 from https://www. uptodate.com/contents/alcohol-use-disorder- pharmacologic-management 216. U.S. Department of Veterans Affairs. (2021). VA/ DoD clinical practice guideline for the management of substance use disorders. Retrieved September 6, 2022 from https://www.healthquality.va.gov/ guidelines/mh/sud
44
Powered by FlippingBook